what are the Recommendations for Renin-Angiotensin System Inhibition With ACe Inhibitor or ARb or ARNI?
the clinical strategy of inhibition of the renin-angiotensin system with ACe inhibitors (Level of Evidence: A),9?14 oR ARbs (Level of Evidence: A),15?18 oR ARNI (Level of Evidence: B-R)19 in conjunction with evidence- based beta blockers,20?22 and aldosterone antagonists in selected patients,23,24 is recommended for patients with chronic HFr eF to reduce morbidity and mortality.